175 results on '"Conklin, Laurie S."'
Search Results
2. Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
3. The Role of Master Protocols in Pediatric Drug Development
4. Therapeutics for Inflammatory Bowel Diseases in Children and Adolescents: A Focus on Biologics and an Individualized Treatment Paradigm
5. Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of Similarity Among Participants with Adolescent-onset and Adult-onset Disease.
6. Catheter-Related Venous Thrombosis in Hospitalized Pediatric Patients with Inflammatory Bowel Disease: Incidence, Characteristics, and Role of Anticoagulant Thromboprophylaxis with Enoxaparin
7. Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience
8. Therapeutics for Inflammatory Bowel Diseases in Children and Adolescents: A Focus on Biologics and an Individualized Treatment Paradigm
9. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease
10. Towards the international interoperability of clinical research networks for rare diseases:recommendations from the IRDiRC Task Force
11. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
12. Acute Hepatitis
13. Contributors
14. Inflammatory Bowel Disease
15. Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
16. Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
17. Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation
18. Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity
19. TECHNIQUES, TECHNOLOGY & ANALYSIS: POSITION PAPER: The potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction
20. Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity.
21. VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis
22. Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development
23. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD
24. Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease
25. Medical Malpractice in Gastroenterology
26. Detergent Pod Ingestions in Young Children: A Case Series
27. Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function
28. Inflammatory Bowel Disease
29. Acute Hepatitis
30. Contributors
31. 6-mercaptopurine transport in human lymphocytes: Correlation with drug-induced cytotoxicity
32. Early Inflammatory Markers are Associated With Inadequate Post-Induction Infliximab Trough in Pediatric Crohn's Disease
33. Exposure‐Response Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy
34. Nutritional considerations in pediatric inflammatory bowel disease
35. Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohnʼs disease
36. Gastric suction at birth
37. 60 - Acute Hepatitis
38. Developmental Pharmacodynamics and Modeling in Pediatric Drug Development
39. Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy
40. Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
41. Early Inflammatory Markers are Associated With Inadequate Post-Induction Infliximab Trough in Pediatric Crohn's Disease.
42. Position paper: The potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction
43. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
44. Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys.
45. Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
46. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn’s & Colitis Foundation: Charting the Future of Pediatric IBD
47. Obesity and Pediatric Drug Development
48. P036 EXPLORING EARLY-RESPONSIVE PHARMACODYNAMIC BIOMARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD)
49. The potential role of optical biopsy in the study and diagnosis of environmental enteric dysfunction
50. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.